You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
內地下月8日起取消入境後集中隔離 48小時內核酸檢測陰性可入境
國家衛健委宣布,將新型冠狀病毒肺炎更名為新型冠狀病毒感染。依據國境衛生檢疫法,不再對入境人員和貨物等採取檢疫傳染病管理措施。 經國務院批准,自明年1月8日起,解除對新型冠狀病毒感染採取的甲類傳染病預防、控制措施從「乙類甲管」調整為「乙類乙管」,不再實行隔離措施,不再判定密切接觸者;不再劃定高低風險區;對感染者實施分級分類收治並適時調整醫療保障政策及檢測策略調整為「願檢盡檢」等。 具體包括:優化中外人員往來管理。來華人員在行前48小時進行核酸檢測,結果陰性者可來華,毋須向駐外使領館申請健康碼,將結果填入海關健康申明卡。如呈陽性,相關人員應在轉陰後再來華。取消入境後全員核酸檢測和集中隔離。健康申報正常且海關口岸常規檢疫無異常者,可放行進入社會面。 同時,加快提高疫苗加強免疫接種覆蓋率,特別是老年人群覆蓋率,優先採取序貫加強免疫,努力做到「應接盡接」。在第一劑次加強免疫接種基礎上,在感染高風險人群、60歲及以上老年人群、具有較嚴重基礎疾病人群和免疫力低下人群中推動開展第二劑次加強免疫接種。(ta/w) ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account